Mk2 Biotechnologies

Developer of peptides and proteins for life science applications

placeMunich, Bavaria, Germany calendar_todayFounded 2017 groups15 employees language mk2.bio

Registered entities

Innovation

2 patent families — focus: Chemistry & metallurgy, Physics & computing; filing pace accelerating. Cited 57 times.

YearFilings
20231
20241
20252

Investor mix

3 investors on record; lead investors include OCCIDENT.

Investor typeCountShare
Venture capital133%
Other / undisclosed267%
Coming soon